Medical
Pharmaceutical
Health

Therapix Biosciences

$4.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-2.10%) Today
+$0.05 (1.19%) After Hours

Why Robinhood?

You can buy or sell TRPX and other stocks, options, ETFs, and crypto commission-free!

About

Therapix Biosciences Ltd. American Depositary Shares, also called Therapix Biosciences, is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. Read More It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

Employees
Headquarters
Tel Aviv, Tel Aviv
Founded
2004
Market Cap
14.69M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
140.68K
High Today
$4.35
Low Today
$4.20
Open Price
$4.35
Volume
7.58K
52 Week High
$9.30
52 Week Low
$3.00

Collections

Medical
Pharmaceutical
Health
Biotechnology
Technology
2017 IPO
US
North America

Earnings

-$0.59
-$0.49
-$0.40
-$0.30
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.